|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4866 USD | +12.10% |
|
-6.31% | +8.13% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.91M 1.76M 1.64M 3.09M 207M 3.15M 21.14M 8.19M 101M 8.17M 7.99M 353M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.84M 10.9M 10.15M 19.15M 1.28B 19.54M 131M 50.77M 629M 50.62M 49.53M 2.19B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | +12.10% | ||
| 1 week | -6.31% | ||
| Current month | +12.09% | ||
| 1 month | +10.59% | ||
| 3 months | +62.20% | ||
| 6 months | +11.86% | ||
| Current year | +8.13% |
| 1 week | 0.43 |  | 0.52 |
| 1 month | 0.39 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 15/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 30/03/2016 |
| Director of Finance/CFO | 46 | 20/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 26/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 16/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 15/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.10% | -6.31% | +21.65% | -42.75% | 3.15M | |
| -0.64% | +6.67% | +53.59% | +158.28% | 1,070B | |
| +0.00% | +5.39% | +62.89% | +55.48% | 611B | |
| -0.23% | +6.88% | +32.14% | +85.96% | 445B | |
| -3.05% | +4.18% | +31.11% | +23.88% | 329B | |
| -1.74% | +1.94% | +36.90% | +22.86% | 290B | |
| -1.25% | +1.28% | +29.98% | +38.89% | 287B | |
| +2.99% | +5.28% | -26.30% | -41.06% | 213B | |
| -0.22% | +2.82% | +24.37% | +60.58% | 195B | |
| -0.29% | +0.65% | +12.75% | +64.21% | 157B | |
| Average | +0.70% | +4.54% | +27.91% | +42.63% | 359.62B | |
| Weighted average by Cap. | -0.60% | +6.67% | +39.14% | +77.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.26M 18.65M 17.37M 32.77M 2.19B 33.43M 224M 86.89M 1.08B 86.62M 84.75M 3.75B | 24.22M 21.26M 19.57M 18.24M 34.39M 2.3B 35.09M 235M 91.2M 1.13B 90.92M 88.95M 3.93B |
| Net income | -5.27M -4.62M -4.26M -3.97M -7.48M -501M -7.63M -51.2M -19.84M -246M -19.78M -19.35M -855M | -3.2M -2.81M -2.59M -2.41M -4.55M -305M -4.64M -31.13M -12.06M -149M -12.03M -11.77M -520M |
| Net Debt | 10.2M 8.95M 8.24M 7.68M 14.48M 969M 14.78M 99.12M 38.4M 476M 38.29M 37.46M 1.66B | 11.31M 9.93M 9.14M 8.51M 16.06M 1.07B 16.38M 110M 42.58M 528M 42.45M 41.54M 1.84B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$0.4866 | +12.10% | 100 |
| 30/06/26 | US$0.4341 | -16.43% | 1,000 |
| 25/06/26 | US$0.5194 | -0.02% | 1,500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
